FilingPulse

BOLT insider transaction filings

Bolt Biotherapeutics, Inc. — 28 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-11. Screen BOLT transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-114Berner Laura — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2026-06-114Dupont Jakob — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2026-06-114O'CALLAGHAN BRIAN — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2026-06-114ONETTO NICOLE — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2026-06-114LAPORTE KATHLEEN — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2026-02-044Quinn William P. — President, CEO and CFO, DirectorPurchase (P): 125 @ $4.61 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-02-044Nemec Sarah — Senior VP, Finance and PAOPurchase (P): 125 @ $4.61 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2026-02-044Yonehiro Grant — Chief Operating OfficerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-12-164Berner Laura — DirectorGrant/award (A): 2,500 (derivative) · Disposition to issuer (D): 2,500 (derivative) · Grant/award (A): 613 (derivative) · Disposition to issuer (D): 613 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 1,250 (derivative) · +4 moreEDGAR
2025-12-164Nemec Sarah — Senior VP, Finance and PAOGrant/award (A): 1,236 (derivative) · Disposition to issuer (D): 1,236 (derivative) · Grant/award (A): 375 (derivative) · Disposition to issuer (D): 375 (derivative) · Grant/award (A): 600 (derivative) · Disposition to issuer (D): 600 (derivative) · +12 moreEDGAR
2025-12-164Quinn William P. — President, CEO and CFO, DirectorGrant/award (A): 7,614 (derivative) · Disposition to issuer (D): 7,614 (derivative) · Grant/award (A): 3,927 (derivative) · Disposition to issuer (D): 3,927 (derivative) · Grant/award (A): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +10 moreEDGAR
2025-12-164Dupont Jakob — DirectorGrant/award (A): 2,500 (derivative) · Disposition to issuer (D): 2,500 (derivative) · Grant/award (A): 849 (derivative) · Disposition to issuer (D): 849 (derivative) · Grant/award (A): 1,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · +2 moreEDGAR
2025-12-164Yonehiro Grant — Chief Operating OfficerGrant/award (A): 3,214 (derivative) · Disposition to issuer (D): 3,214 (derivative) · Grant/award (A): 660 (derivative) · Disposition to issuer (D): 660 (derivative) · Grant/award (A): 822 (derivative) · Disposition to issuer (D): 822 (derivative) · +18 moreEDGAR
2025-12-164O'CALLAGHAN BRIAN — DirectorGrant/award (A): 1,393 (derivative) · Disposition to issuer (D): 1,393 (derivative) · Grant/award (A): 1,810 (derivative) · Disposition to issuer (D): 1,810 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 1,250 (derivative) · +6 moreEDGAR
2025-12-164ONETTO NICOLE — DirectorGrant/award (A): 1,393 (derivative) · Disposition to issuer (D): 1,393 (derivative) · Grant/award (A): 1,107 (derivative) · Disposition to issuer (D): 1,107 (derivative) · Grant/award (A): 611 (derivative) · Disposition to issuer (D): 611 (derivative) · +8 moreEDGAR
2025-12-164LAPORTE KATHLEEN — DirectorGrant/award (A): 1,392 (derivative) · Disposition to issuer (D): 1,392 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 1,250 (derivative) · +8 moreEDGAR
2025-10-244Nemec Sarah — Senior VP, Finance and PAOPurchase (P): 125 @ $5.49 · Grant/award (A): 23,000 @ $0EDGAR
2025-10-244Quinn William P. — President, CEO and CFO, DirectorPurchase (P): 125 @ $5.49 · Grant/award (A): 40,000 @ $0EDGAR
2025-10-244Yonehiro Grant — Chief Operating OfficerGrant/award (A): 30,000 @ $0EDGAR
2025-07-024Berner Laura — DirectorGrant/award (A): 1,100 (derivative) @ $0EDGAR
2025-07-024Dupont Jakob — DirectorGrant/award (A): 1,100 (derivative) @ $0EDGAR
2025-07-024O'CALLAGHAN BRIAN — DirectorGrant/award (A): 1,100 (derivative) @ $0EDGAR
2025-07-024ONETTO NICOLE — DirectorGrant/award (A): 1,100 (derivative) @ $0EDGAR
2025-07-024LAPORTE KATHLEEN — DirectorGrant/award (A): 1,100 (derivative) @ $0EDGAR
2025-05-054Nemec Sarah — Senior VP, Finance and PAOPurchase (P): 2,500 @ $0.50 · Purchase (P): 2,500 @ $0.64 · Grant/award (A): 226,000 (derivative) @ $0EDGAR
2025-05-054Quinn William P. — President, CEO and CFO, DirectorPurchase (P): 2,500 @ $0.50 · Purchase (P): 2,500 @ $0.64 · Grant/award (A): 700,000 (derivative) @ $0EDGAR
2025-05-054Dupont Jakob — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-05-054Yonehiro Grant — Chief Operating OfficerGrant/award (A): 350,000 (derivative) @ $0EDGAR

Recent 8-K events — Bolt Biotherapeutics, Inc.

FiledFormItems reportedSource
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-10-028-K?
8.01 — Other Events		EDGAR
2025-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-068-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year		EDGAR
2025-06-048-K8.01 — Other EventsEDGAR
2025-05-288-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BOLT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →